论文部分内容阅读
目的 分析评价胆道多支架植入术对肝门部高位恶性胆道梗阻的临床疗效及应用价值。方法 58例肝门部胆道梗阻病人,单支架植入26例,多支架植入32 例。结果 单支架、多支架植入成功率分别为100%和93. 75%(P>0 .05);术后胆红素下降率分别为64 .12%和75 .54%(P<0 05);单支架和多支架6 个月、12 个月、18 个月的生存率分别为78. 82%、38 .43%、8 .87%和88 .17%、45. 16%、19. 35%(P<0 .05);并发症发生率分别为26 .93%和25. 00%(P>0. 05)。结论 肝门部胆道狭窄多支架植入同单支架植入比较能更有效地解除黄疸,延长生存期,且成功率及并发症同单支架术无显著性差异,是值得临床推广应用的介入治疗技术。
Objective To evaluate the clinical efficacy and application value of multi-stent-graft in the treatment of high-grade malignant biliary obstruction in hilar. Methods 58 cases of hilar biliary obstruction patients, single stent implantation in 26 cases, multiple stent implantation in 32 cases. Results The successful rates of single stent and multi-stent implantation were 100% and 93.75%, respectively (P> 0.05), and the rates of postoperative bilirubin descent were 64.12% and 75.54%, respectively ). The survival rates of single-stent and multi-stent at 6 months, 12 months and 18 months were 78.82%, 38.43%, 8.87% and 88.17%, 45.16%, 19 respectively. The incidence of complications was 26.93% and 25. 00% respectively (P> 0.05). Conclusions Compared with single stenting, hilar stenosis and multi-stent implantation can effectively relieve jaundice and prolong survival, and the success rate and complications are not significantly different from those of single stenting, which is worthy of clinical application technology.